- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00132457
Use of Self-collected Vaginal Swabs as an Innovative Approach to Facilitate Testing for Repeat Chlamydia Infection
January 6, 2010 updated by: Centers for Disease Control and Prevention
The purpose of this study is to determine if, among women who were treated for a prior chlamydial infection, home-based, self-collected vaginal swabs can increase rescreening for chlamydia in comparison with rescreening in the clinic.
The study design is two randomized trials with enrollment at multiple family planning clinics and sexually transmitted disease (STD) clinics following a common protocol.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The study consists of two complementary trials, denoted as Part A and Part B. In Part A, women/girls who had a positive test for chlamydia will be enrolled when they visit the study clinics for treatment.
After written informed consent is obtained, women will be randomly assigned to the Clinic Group, in which they will be advised to return to the clinic for rescreening for chlamydia, or the Home Group, in which women will be asked to collect a vaginal swab at home and mail it to the study laboratory for chlamydia testing.
In part B, women who were tested and empirically treated for a chlamydial infection will be called if their tests were positive.
Enrollment will be offered over the phone after verbal consent.
Rescreening will be scheduled 3 months after treatment of the initial infection for women in both trials.
Study Type
Interventional
Enrollment (Anticipated)
1830
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Louisiana
-
New Orleans, Louisiana, United States, 70112
- Louisiana State University (LSU) Health Sciences Center
-
-
Mississippi
-
Jackson, Mississippi, United States, 39216
- The Mississippi State Department of Health, Bureau of STD/HIV
-
-
Missouri
-
St Louis, Missouri, United States, 63110
- Washington University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years and older (Child, Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Women/girls with a lab-confirmed genital chlamydia infection
Exclusion Criteria:
- Women who are pregnant, or are trying to conceive in the following 3 months.
- Women who are planning to move in the following 3 months or currently living outside the study areas.
- Inability to understand spoken English adequately to assure informed consent and compliance with study procedures.
- Self-reported HIV infection; other serious illnesses or disability.
- Self-reported allergy to macrolide antibiotics such as azithromycin.
- Referrals from providers or clinics other than the STD or family planning clinics, unless women are re-tested at the STD clinics and test positive for chlamydia.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
---|
Percent of women rescreened for chlamydia
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Fujie Xu, Centers for Disease Control and Prevention
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2003
Primary Completion (Actual)
September 1, 2008
Study Completion (Actual)
September 1, 2008
Study Registration Dates
First Submitted
August 18, 2005
First Submitted That Met QC Criteria
August 18, 2005
First Posted (Estimate)
August 22, 2005
Study Record Updates
Last Update Posted (Estimate)
January 7, 2010
Last Update Submitted That Met QC Criteria
January 6, 2010
Last Verified
January 1, 2010
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CDC-NCHSTP-4274
- U36/CCU319276
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chlamydia Infections
-
National Institute of Allergy and Infectious Diseases...CompletedAnal Chlamydia InfectionUnited States
-
Statens Serum InstitutImperial College LondonCompletedChlamydia TrachomatisUnited Kingdom
-
Gen-Probe, IncorporatedWithdrawnChlamydia TrachomatisUnited States
-
University of PittsburghAgency for Healthcare Research and Quality (AHRQ)Completed
-
Assistance Publique - Hôpitaux de ParisNational Reference Center (NRC) for Chlamydia infections, UMR1181CompletedGenital Chlamydia Trachomatis InfectionFrance
-
Maastricht University Medical CenterCompletedChlamydia Trachomatis InfectionNetherlands
-
Arkansas Children's Hospital Research InstituteNational Institutes of Health (NIH)Completed
-
Region ÖstergötlandUnknownChlamydia Trachomatis Genital Infection | Chlamydia Trachomatis Infection of Anus and RectumSweden
-
University of North Carolina, Chapel HillSouthern Medical University, ChinaRecruitingChlamydia Trachomatis InfectionChina
-
Arkansas Children's Hospital Research InstituteWithdrawnChlamydia InfectionUnited States
Clinical Trials on Self-collected vaginal swab for chlamydia testing
-
Médecins du MondeNational Cancer Institute, FranceUnknown
-
National University Hospital, SingaporeUnknownCervical Cancer | Human Papillomavirus Infection | Cervical Dysplasia
-
St George's, University of LondonCompletedChlamydia Infections | Pelvic Inflammatory DiseaseUnited Kingdom
-
International Vaccine InstituteLondon School of Hygiene and Tropical Medicine; Karolinska Institutet; Centers...Not yet recruitingHPV InfectionZambia, Bangladesh, Congo, The Democratic Republic of the, Ghana, Nepal, Pakistan, Sierra Leone, Tanzania
-
McMaster UniversityMerck Frosst Canada Ltd.; Public Health Agency of Canada (PHAC); Juravinski Cancer...UnknownCervical Intraepithelial Neoplasia | Human Papillomavirus InfectionCanada
-
Anne's Day LtdCareggi Hospital; Lindus HealthActive, not recruitingChlamydia | Gonorrhea | Human Papilloma Virus | Bacterial VaginosisUnited Kingdom
-
University Hospital, ToursCompletedCervical Cancer | Human Papillomavirus Infection
-
University Hospitals Coventry and Warwickshire...Abbott; Copan Italia SPA , Via F. Perotti, 10, 25125 Brescia, ItalyWithdrawnCervix DiseasesUnited Kingdom
-
University of Wisconsin, MadisonMilwaukee Consortium for Hmong Health (MCHH)CompletedCervical Cancer ScreeningUnited States
-
Queen Mary University of LondonCompleted